Insulin

Insulin is a 51-amino-acid peptide hormone and the single most powerful anabolic signal the human body produces. It works by binding the insulin receptor (IR) — a heterotetrameric α₂β₂ receptor tyrosine kinase expressed densely on skeletal muscle, liver, and adipose tissue. Ligand binding triggers trans-autophosphorylation of the β-subunits, recruits IRS-1/2, and branches into two functionally distinct arms: a metabolic arm (PI3K/Akt) that drives nutrient uptake and anti-catabolism, and a mitogenic arm (Ras/MAPK) that overlaps with IGF-1 signalling. For the post-workout bodybuilder, almost everything that matters happens on the PI3K side.

"The metabolic actions of insulin are largely accounted for by activation of the PI3K pathway, whereas the mitogenic actions are mediated by the Ras/MAP kinase pathway." — Saltiel AR, Kahn CR, Nature (2001)

GLUT4 Translocation and Nutrient Shuttling#

The Akt-driven headline effect is GLUT4 translocation. In the resting state, GLUT4 glucose transporters sit in intracellular vesicles; insulin signalling (and, independently, muscle contraction) shuttles them to the sarcolemma, opening the door for glucose to flood into the muscle cell. Along for the ride come amino acids (via upregulated transporters like SNAT2 and LAT1), creatine, and electrolytes — particularly potassium and phosphate.

This is why the post-workout shot works: you've just finished training, GLUT4 is already membrane-bound from contraction, and insulin stacks on top of that signal to supercharge glycogen refill and intramuscular amino acid loading. It's also why hypokalemia is a real concern at higher doses — potassium follows glucose into the cell, and serum levels drop.

mTOR Activation and Net Protein Balance#

Akt activates mTORC1, which phosphorylates 4E-BP1 and S6K1 to initiate translation. But the more important — and often misunderstood — mechanism is on the breakdown side. Insulin is a potent anti-catabolic: it suppresses proteolysis in skeletal muscle whether or not it directly stimulates synthesis.

"Insulin acutely and dose-dependently inhibits protein breakdown in skeletal muscle, with little or no direct stimulatory effect on protein synthesis in the presence of ample amino acids." — Gelfand RA, Barrett EJ, Journal of Clinical Investigation (1987)

"Net protein synthesis occurred only when insulin was increased to physiologic postprandial concentrations and hyperaminoacidemia was maintained." — Biolo G et al., Diabetes (1995)

Read those two citations together and you have the entire practical rationale for bodybuilding slin use: insulin shifts net protein balance positive by slamming the brakes on breakdown, but only when amino acids are flooding in at the same time. Eat the steak. Drink the shake. Land the carbs. Injecting without a post-shot meal doesn't just risk a hypo — it squanders the anabolic window entirely.

Glycogen Super-Compensation#

Akt also inhibits glycogen synthase kinase-3β (GSK-3β), which in turn releases glycogen synthase from its inhibited state. With GLUT4 open and glycogen synthase active, depleted post-workout muscle becomes a glycogen sink. This is the mechanism behind the fuller, rounder look lifters notice within days of starting a slin protocol — the muscle bellies are storing more glycogen (and the ~3g of bound water per gram of glycogen that comes with it).

Practical consequence: a lot of the early scale weight on slin is glycogen plus intracellular water, not tissue. That's not a criticism — a fuller, better-pumped muscle trains harder, looks better, and creates a more anabolic mechanical environment. Just don't confuse week-one bloat with tissue accrual.

Lipogenic Drive and Why Slin Is Not a Fat-Loss Tool#

In adipose tissue, insulin simultaneously activates lipoprotein lipase (LPL) — pulling circulating fatty acids into the fat cell — and suppresses hormone-sensitive lipase (HSL), shutting down lipolysis. This is the mechanism that makes insulin the single most lipogenic signal in human physiology.

The corollary is unambiguous: insulin is an anabolic compound, not a fat-loss compound. Running it in a caloric deficit is physiologically possible but wastes the mechanism; running it in a significant surplus will add fat alongside lean tissue at a clip matched only by heavy oral AAS. The community uses slin during bulk blocks for a reason.

GH / Insulin Synergy — The Bodybuilding Rationale#

Exogenous growth hormone is strongly lipolytic and induces a state of transient insulin resistance — fasting glucose climbs, the liver becomes less responsive to insulin's suppression of gluconeogenesis, and once GH doses push past ~4 IU/day most users start creeping into pre-diabetic fasting glucose territory. This is where the "GH + slin trinity" pattern (test + GH + insulin) comes from: GH handles fat oxidation and connective tissue, exogenous insulin overrides GH-induced glucose intolerance and restores the anabolic nutrient-partitioning signal, and testosterone provides the tissue-building androgen backbone on top. Each compound covers a weakness in the other two. It's also why physique users rarely run insulin as a standalone — solo slin in an otherwise-natural endocrine system delivers glycogen and water and modest anti-catabolism, but the dramatic tissue accrual that slin has a reputation for requires GH and AAS running underneath it.

Analog Pharmacology — Why Lispro Is the Bodybuilding Default#

Regular human insulin (Humulin R) hexamerizes in solution and has to dissociate before it can be absorbed, giving a 30–60 min onset and a 5–8 h tail. The rapid-acting analogs — lispro (Humalog), aspart (Novolog), glulisine (Apidra) — have single amino-acid substitutions that prevent hexamer stabilization, producing a cleaner, faster, shorter pharmacokinetic profile.

"The newer rapid-acting and long-acting insulin analogues provide more predictable absorption, peak, and duration profiles, which are crucial for tailoring therapy to individual requirements." — Evans M et al., Diabetes Obes Metab (2011)

For post-workout use, "more predictable" and "shorter" are exactly what you want. A 10–20 min onset matches the post-training feeding window, the 45–90 min peak aligns with the first post-workout meal, and a 3–5 h duration means your hypoglycemia risk window closes before bedtime. That's why Humalog and Novolog are the community standard, not regular insulin or long-acting analogs. Long-acting insulins (glargine, degludec) have no role in a bodybuilding protocol — a 24+ hour hypoglycemia tail with no defined feeding window is simply a way to die in your sleep.

Common (most users)#

• Mild hypoglycemia (shakiness, sweating, hunger, irritability 60–180 min post-shot) — the single most frequent experience. Mitigation: 15–20 g fast carbs on hand (dextrose tabs, juice, regular soda), recheck glucose in 15 min, repeat if still <70 mg/dL. Keep eating through the full active window (~4–5 h for lispro/aspart) — not just the immediate post-shot meal.
• Post-shot sleepiness / "food coma" — driven by the rapid glucose drop plus a large carb+protein meal. Manageable: eat the meal sitting down somewhere safe, avoid driving for the first 90 min, and never inject and then nap.
• Injection site irritation / small bruises — use 4–6 mm 31G slin pins, rotate abdominal sites on a grid, pinch a fold of skin for SC delivery.
• Scale weight jump in the first week — mostly glycogen + intracellular water, not tissue. Expected and desired; do not interpret as fat gain and do not pull carbs to compensate.
• Mild edema / puffy face — sodium/water shift early in the cycle. Usually settles within 7–10 days. Potassium-rich foods help; do not reach for diuretics.

Uncommon (dose-dependent or individual)#

• Moderate hypoglycemia (confusion, slurred speech, sweating with impaired coordination) — you under-ate carbs, the shot went partially IM, or you trained/showered/drove after injecting and accelerated absorption. Mitigation: 30+ g fast carbs immediately, sit down, have someone with you. If this happens, your protocol is broken — drop the dose by 2 IU next session and audit what went wrong before increasing again.
• Lipohypertrophy at repeated injection sites — rubbery subcutaneous lumps that absorb erratically and make future dosing unpredictable. Rotate sites aggressively; avoid lumps for at least 2 weeks once they form.
• Fat gain outstripping lean gain — insulin does not care where the carbs go once glycogen is full. If bodyfat is climbing faster than the mirror is improving, carbs are too high, not insulin too low.
• Rising fasting glucose and HbA1c on long GH+slin runs — check HbA1c every 3–6 months. If fasting glucose trends above 110 mg/dL off-cycle or HbA1c clears 5.7%, take time off and add cardio.
• Hypokalemia at higher doses or stacked with diuretics pre-contest — cramping, palpitations. Pull back dose, add potassium-rich food, and reconsider the diuretic protocol.

"Massive overdose causes prolongation of the half-life of injected insulin, and hypoglycemia can continue for a long period." — Matsumura et al. 2018, Kobe J Med Sci

That quote is the reason dose discipline matters: a 20 IU "mistake" does not behave like two 10 IU shots. Clearance slows, the tail drags, and the hypo window can run 6–12+ hours.

Rare but serious#

• Severe hypoglycemia (seizure, loss of consciousness, coma) — medical emergency. Warning signs: you feel "off" but can't articulate why, vision tunnels, you get argumentative or emotional with no cause, fine motor skills degrade. Stop, test, eat. If a user is unresponsive or can't swallow safely, a training partner administers glucagon (1 mg IM kit or Baqsimi 3 mg intranasal) and calls emergency services. Do not pour liquid carbs into an unconscious person's mouth.
• Hypoglycemia-induced cardiac events — the catecholamine surge from a bad hypo can trigger arrhythmia or ischemia in users with underlying cardiovascular disease (including AAS-driven hypertension / LVH). This is why untreated cardiovascular disease is a hard stop.
• Chronic insulin resistance / pre-diabetic metabolic damage from multi-year uninterrupted use, especially stacked with GH. Fasting insulin climbing, HOMA-IR >2.5, HbA1c >5.9% — stop, run cardio, diet down, cycle off for months.
• Death from injecting and going to sleep — the most common lethal pattern in bodybuilding. Pre-sleep injection is a hard contraindication for a reason: you cannot feel a hypo that starts while you're unconscious.

Hard contraindications#

State these plainly — they are the lines that do not get crossed.

• Insulin + fasted training. Do not inject without the post-workout meal already prepared and carbs measured. Training drives GLUT4 translocation independent of insulin; stacking a shot on top of an already-depleted fasted athlete is how people end up on the gym floor.
• Insulin + skipped post-injection meal. If the food isn't on the counter when the needle goes in, the shot does not happen. "I'll eat in a bit" is how hypos start.
• Insulin + pre-sleep injection. The 4–6 h active window of a rapid analog (longer at high doses) must be fully covered by waking, eating hours. Never inject within 5 h of bedtime.
• Insulin + alcohol within the active window. Alcohol blocks hepatic gluconeogenesis — your liver can't bail you out of a hypo. A drunk hypo is also easy to misread as "just drunk."
• Injecting alone in the house. Somebody who can identify a hypo and administer glucagon needs to be within reach. No exceptions on high-dose or first-time-at-a-new-dose shots.
• No glucometer and no fast carbs on hand. Non-negotiable kit: meter, 40+ g fast carbs, glucagon rescue.
• Untreated cardiovascular disease or severe uncontrolled hypertension. The catecholamine response to a hypo can kill a compromised heart.
• Pen click-dosing after a few drinks, late at night, or when tired. Draw from the vial with a U-100 slin pin and count the units visually. Pen misdials are a top-three cause of reported overdoses.

Gender and PCT considerations#

No HPTA suppression — insulin is not a steroid and requires no PCT. Women respond identically at the receptor level; scale dose to lean mass, which usually puts female users at the low end of the male ranges (2–6 IU post-workout). Pregnancy is not a contraindication to therapeutic insulin (it's standard of care for gestational diabetes), but the bodybuilding use-case — supraphysiologic post-workout dosing for mass — has no place in pregnancy and should be stopped during any conception window.